Work

Notch signaling: An emerging therapeutic target for cancer treatment

Year: 2015
Type: review
Abstract: The Notch pathway is involved in cell proliferation, differentiation and survival. The Notch signaling pathway is one of the most commonly activated signaling pathways in cancer. Alterations include activating mutations and amplification of the Notch pathway, which play key roles in the progression of cancer. Accumulating evidence suggests that the pharmacological inhibition of this pathway can overcome chemoresistance. Efforts have been taken to develop Notch inhibitors as a single agent or in combination with clinically used chemotherapeutics to treat cancer. Some Notch inhibitors have been demonstrated to have therapeutic efficacy in preclinical studies. This review summarizes the recent studies and clinical evaluations of the Notch inhibitors in cancer.
Language: English
Open Access status: hybrid
Estimated APC paid: $4,960
OpenAlex ID: W2133708523
FWCI: 4.159
Cites: 92
Cited by: 424
Related to: 10